Dec 18 (Reuters) - Novavax Inc NVAX.O:
NOVAVAX INC - ON DEC 12, ENTERED AMENDMENT 5 TO ADVANCED PURCHASE AGREEMENT WITH COMMONWEALTH OF AUSTRALIA
NOVAVAX- ACKNOWLEDGED COMMONWEALTH CANCELLATION OF DELIVERING CERTAIN DOSES OF CO’S COVID-19 VACCINE SCHEDULED FOR DELIVERY BETWEEN Q4 2023 & Q4 2025
NOVAVAX- AGREED TO UPDATED DELIVERY SCHEDULE FOR POTENTIAL DELIVERY OF COVID-19 VACCINE/FUTURE VARIANT COVID-19 VACCINE THROUGH END OF 2029
Source text: [ID:n0001104659-24-129823]
Further company coverage: NVAX.O
((Reuters.Briefs@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。